Georgetown University — Washington D.C., District of Columbia

Public research footprint of Georgetown University, compiled from the ClinicalTrials.gov public registry.

1,677

Registered studies

439

Active

189

Recruiting now

888

Completed

271

Stopped or withdrawn

Most-studied conditions

Lymphoma · Stage II Lung Non-Small Cell Cancer AJCC v7 · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07707895 — DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With… (Not Yet Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Georgetown University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.